Genetic Variant as a Selection Marker for Anti–Prostate Stem Cell Antigen Immunotherapy of Bladder Cancer

A monoclonal antibody against prostate stem cell antigen (PSCA) has emerged as a novel cancer therapy currently being tested in clinical trials for prostate and pancreatic cancers, but this treatment is likely to be efficient only in patients with PSCA-expressing tumors. The present study demonstrat...

詳細記述

保存先:
書誌詳細
主要な著者: Kohaar, Indu, Porter-Gill, Patricia, Lenz, Petra, Fu, Yi-Ping, Mumy, Adam, Tang, Wei, Apolo, Andrea B., Rothman, Nathaniel, Baris, Dalsu, Schned, Alan R., Ylaya, Kris, Schwenn, Molly, Johnson, Alison, Jones, Michael, Kida, Masatoshi, Silverman, Debra T., Hewitt, Stephen M., Moore, Lee E., Prokunina-Olsson, Ludmila
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2013
主題:
Brief Communication
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3536639/
https://ncbi.nlm.nih.gov/pubmed/23266392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djs458
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料